Oseltamivir prescribing, United States, 2004-2005

被引：16

作者：

Ortiz, Justin R. ^{[1
]}

Kamimoto, Laurie ^{[1
]}

Aubert, Ronald E. ^{[2
]}

Yao, Jianying ^{[2
]}

Shay, David K. ^{[1
]}

Bresee, Joseph S. ^{[1
]}

Epstein, Robert S. ^{[2
]}

机构：

[1] Ctr Dis Control & Prevent, Atlanta, GA USA

[2] Medco Hlth Solut Inc, Franklin Lakes, NJ USA

来源：

EMERGING INFECTIOUS DISEASES | 2008年 / 14卷 / 08期

关键词：

D O I：

10.3201/eid1408.080074

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We reviewed information from a US pharmacy benefits manager database from 2004 through 2005 during periods with little influenza activity. We calculated rates of oseltamivir prescriptions to enrollees. Prescription rates increased significantly from 27.3/100,000 in 2004 to 134/100,000 in 2005 (p < 0.05), which suggested that personal stockpiling of oseltamivir occurred.

引用

页码：1280 / 1283

页数：4

共 11 条

[1]

Dooley Samuel W., 2008, Morbidity and Mortality Weekly Report, V57, P1

[2]

Blanton L., 2006, Morbidity and Mortality Weekly Report, V55, P648

[3] The run on Tamilflu - Should physicians prescribe on demand? [J].